The embryonic transcriptional program activated by the potent DUX4 pioneer transcription factor likely explains the many disparate effects described in FSHD muscle including interference with metabolism, RNA processing and myogenic differentiation. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.